v3.26.1
Summary of Significant Expense Categories (Details) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting [Line Items]    
Revenues $ 6,543,001 $ 5,065
Cost of revenues (11,071) (4,052)
Gross Profit 6,531,930 1,013
Research and development expenses    
Total research and development expenses 1,257,948 1,478,711
Manufacturing and materials (1,257,948) (1,478,711)
General and administrative    
Total general and administrative expenses 1,833,277 2,227,597
Total operating expenses 3,296,221 1,966,815
Net segment income (loss) 3,472,480 (2,196,875)
Interest expense 109,274 255,822
Indirect tax expense 198,146
Change in fair value of warrant liability (667,343)
Other income, net 8,888 24,749
Manufacturing and Materials [Member]    
Research and development expenses    
Total research and development expenses 9,959 262,798
Manufacturing and materials (9,959) (262,798)
Single Reportable Segment [Member]    
Segment Reporting [Line Items]    
Revenues 6,543,001 5,065
Cost of revenues (11,071) (4,052)
Gross Profit 6,531,930 1,013
Research and development expenses    
Total research and development expenses 1,257,948 1,478,711
Manufacturing and materials (1,257,948) (1,478,711)
General and administrative    
Total general and administrative expenses 1,818,864 1,954,538
Other segment items [1] (347,548) (1,235,361)
Total operating expenses 2,729,264 2,197,888
Net segment income (loss) 3,802,666 (2,196,875)
Arbitration legal fees, net 6,850 (1,739,493)
Accretion of fixed bonus upon maturity of Senior Notes, net 14,413 273,059
Interest expense 109,274 255,822
Indirect tax expense 198,146
Change in fair value of warrant liability (667,343)
Other income, net (8,888) (24,749)
Single Reportable Segment [Member] | Salaries Benefits and Related Expenses [Member]    
Research and development expenses    
Total research and development expenses 778,385 701,106
Manufacturing and materials (778,385) (701,106)
General and administrative    
Total general and administrative expenses 523,353 788,490
Single Reportable Segment [Member] | Preclinical Expenses [Member]    
Research and development expenses    
Total research and development expenses 217,566 177,111
Manufacturing and materials (217,566) (177,111)
Single Reportable Segment [Member] | Clinical Trials [Member]    
Research and development expenses    
Total research and development expenses 127,533 187,820
Manufacturing and materials (127,533) (187,820)
Single Reportable Segment [Member] | Overhead Allocations [Member]    
Research and development expenses    
Total research and development expenses 144,423 149,876
Manufacturing and materials (144,423) (149,876)
Single Reportable Segment [Member] | Professional Services [Member]    
General and administrative    
Total general and administrative expenses [2] 485,137 454,369
Single Reportable Segment [Member] | Facilities and Office Expenses [Member]    
General and administrative    
Total general and administrative expenses 112,912 94,330
Single Reportable Segment [Member] | Depreciation Expenses [Member]    
General and administrative    
Total general and administrative expenses 53,876 61,237
Single Reportable Segment [Member] | Rent and Occupancy Expenses [Member]    
General and administrative    
Total general and administrative expenses 41,162 49,750
Single Reportable Segment [Member] | Insurance [Member]    
General and administrative    
Total general and administrative expenses 194,442 290,269
Single Reportable Segment [Member] | Taxes [Member]    
General and administrative    
Total general and administrative expenses 174,688 32,592
Single Reportable Segment [Member] | Other Expenses [Member]    
General and administrative    
Total general and administrative expenses $ 233,294 $ 183,501
[1] Other segment items include the following unusual or nonrecurring items:
[2] Professional services consist primarily of audit and accounting advisory services, tax advisory services, corporate legal services related to SEC compliance, and legal fees related to patent filings.